Why is #colorectalcancer research so important? Early-onset #CRC is on the rise, while survival rates remain low. But early detection can > survival by 77%. Schedule a #colonoscopy & sign up for the #ARGONAUT study to protect your health & help science. argonautvirtualtrial.com
Could the composition of the #microbiome in early life be contributing to an emerging rise in early-onset #cancer? Researchers from @harvardmed and @BrighamWomens examine the potential reasons behind a dramatic rise in cancer in people under 50. ow.ly/7yh850KHHa8
The #microbiome is associated with virtually every disease we know and it lives in the gut. @PersephoneBio CEO @StephJCuller tells us how studying stool samples💩 can help scientists develop ways to fight disease. #NYSEFloorTalk
🎉 Happy birthday to us! And we're celebrating the 5yr anniversary of our founding with a great gift from forward-thinking investors who are committed to the vast potential of our #AI platform & #synbio tech: $15 million in financing. 🎉
Read more: ow.ly/HNxn50JYTwl
Could the efficacy of #COVID19 vaccines and therapy be improved by strengthening the #microbiome of patients whose gut health is out of balance? There's a lot of evidence that says yes, and here's how it could be done:
ow.ly/v13y50J68VL
Hey Twitter! We’re the VOICES Study team, and we’re so excited to share our program with you. VOICES is a compensated clinical study aimed at involving historically-excluded minority groups in the creation of novel medicines. Enroll now! #JoinVOICES#HealthEquity#microbiome
We recently initiated the ARGONAUT Study, the largest ever clinical study to map the cancer gut microbiome immune axis in the U.S. @PersephoneBio is actively seeking investigators in oncology to collaborate in this ground-breaking study. For more info: persephonebiosciences.com/ar…
The world needs more women-led companies. On November 18th, join YC for their first Future Founder Conference, a virtual event for women globally and learn how to start a startup from inspiring entrepreneurs: ffc2020.ycombinator.com/
#BLUEKNIGHT aims to stimulate the innovation & incubation of potential solutions to protect our communities. Learn more about this collaboration between @JLABS & @BARDA: bit.ly/3llMbe9
Today, we are proud to announce our intent to develop an AI-driven immune-boosting microbiome therapeutic to help prevent and fight #COVID19#JLABSprnewswire.com/news-releases…